This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Microcap Article: Archive
IDT Stock Up Following Q4 Earnings Uptick, Gross Margin Expands
by Zacks Equity Research
IDT's overall topline benefits from revenue growth in the majority of its segments.
IDTPositive Net Change
communications earnings utilities
Zacks Initiates Coverage of Earth Science Tech With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Earth Science Tech as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore ETST's promising growth prospects and financial health amid market challenges.
ETSTNo Net Change
biotechs medical
October Asset Allocation Guidelines
by John Blank
5 different frameworks specify portfolio risk tolerance: from Risky "Max Growth" to Conservative "Income." Choose one that fits you.
asset-allocation
ZRS Chart of the Month
by John Blank
Fall ranks showed two Very Attractive sectors: Industrials and Utilities. Utilities get a strong bid this year, due to "AI" data center energy use growth.
asset-allocation
October Sell-Side and Buy-Side Consensus at a Glance
by John Blank
A valuation boost from the attraction of a broad equity risk premium looks OK using Zacks 2025 S&P500 earnings of $274.17.
asset-allocation
International: Update on Global Regions
by John Blank
The index is more global than one may think. Many U.S. corporations have a global presence, with assets and revenues in or from foreign countries.
asset-allocation
Zacks Initiates Coverage of Rave Restaurant With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Rave Restaurant as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore RAVE's strong earnings growth and financial health amid market challenges.
RAVENegative Net Change
restaurants retail
MiT's Q4 Loss Narrows Y/Y, Revenues Rise on Cinema Demand Recovery
by Zacks Equity Research
MITQ's fiscal Q4 loss narrows to 4 cents per share, while revenues grow 10% to $6.3 million, driven by rising demand for cinema technologies despite industry challenges.
MITQNegative Net Change
business-services earnings
Aerospace Demand Drives Taylor Devices' Y/Y Earnings Growth in Q1
by Zacks Equity Research
TAYD's fiscal Q1 2025 EPS jumps to 85 cents, fueled by robust Aerospace/Defense sales. Revenues increase 17% year over year as the company leveraged strong order flow and strategic investments.
TAYDPositive Net Change
earnings industrial-products
Espey's Q4 Earnings Increase Y/Y on Strong Military Demand
by Zacks Equity Research
ESP reports strong fiscal Q4 results, with EPS jumping to 73 cents and net sales recorded at $11.6 million. The backlog surges to $97.2 million, signaling continued growth momentum.
ESPPositive Net Change
aerospace earnings
FONR's Stock Down Despite Earnings, Revenues Uptick in Fiscal 2024
by Zacks Equity Research
Strength in FONAR's HMCA segment's revenues drives its top line in fiscal 2024.
FONRPositive Net Change
earnings medical medical-devices
RAVE's Earnings, Revenues Rise in Fiscal 2024, Drive Its Stock Up
by Zacks Equity Research
Strength in Rave Restaurant's Pizza Inn Franchising revenues drives its top line in fiscal 2024.
RAVENegative Net Change
earnings restaurants retail
Zacks Initiates Coverage of NeurAxis With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates NeurAxis as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore NRXS' promising growth prospects and financial health amid market challenges.
NRXSPositive Net Change
medical medical-devices
Zacks Initiates Coverage of Kewaunee Scientific With Neutral Recommendation
by Urbashi Dutta
Discover why Zacks rates KEQU as "Neutral," being the first on Wall Street to initiate the coverage of the stock. Explore KEQU's strong order backlog and stable domestic growth amid international challenges and competitive pressures in the laboratory furniture market.
KEQUNegative Net Change
tech-stocks
SigmaTron Incurs Q1 Loss on Soft Demand, Revenues Fall Y/Y
by Zacks Equity Research
SGMA incurs a fiscal Q1 loss of 54 cents per share, with revenues down 14% due to soft demand, though management anticipates improvement by Q4.
computers earnings tech-stocks
2 Small Caps: Do You Bet on the Horse or the Jockey?
by Mark Zinski
Here we highlight two small caps for investors looking for either the strong thoroughbred or the savvy jockey.
TSSINegative Net Change KFSPositive Net Change
artificial-intelligence small-cap
Zacks Initiates Coverage of Kingsway Financial With Neutral Recommendation
by Debanjana Dey
Discover why Zacks rates Kingsway Financial as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore KFS' strategic growth initiatives and financial health amid market challenges.
KFSPositive Net Change
insurance
AXR Stock Flat Despite Q1 Earnings Surge, Improvement in Revenues
by Zacks Equity Research
AMREP's overall top line benefits from growth in all the revenue sources.
AXRNegative Net Change
earnings real-estate
Value Line's Q1 Earnings Increase Y/Y on EAM Growth
by Zacks Equity Research
VALU posted a 21% increase in Q1 net income, fueled by a 48% surge in EAM-related revenue and strong investment gains. Shareholders' equity also rose 3.4% during the quarter.
VALUPositive Net Change
earnings finance
EVI Industries Q4 Earnings Rise Y/Y on Strong Parts and Services Growth
by Zacks Equity Research
EVI reports a 7.7% EPS increase in Q4 2024 despite a 4% drop in revenues, supported by higher-margin parts and services, along with improved gross margins.
EVINegative Net Change
earnings industrial-products
Zacks Initiates Coverage of TSS With Outperform Recommendation
by Urbashi Dutta
Discover why Zacks rates TSSI as "Outperform," being the first on Wall Street to initiate the coverage of the stock. Explore how TSS is well-positioned for long-term success in the data center market despite customer concentration risks and rising inventory.
TSSINegative Net Change
industrial-products
Zacks Initiates Coverage of Healthcare Triangle With Underperform Recommendation
by Debanjana Dey
Discover why Zacks rates Healthcare Triangle as "Underperform", being the first on Wall Street to initiate coverage on the stock. Explore HCTI's heavy reliance on top clients amid liquidity issues and ongoing losses.
HCTINegative Net Change
medical medical-devices
Perma-Pipe's Q2 Earnings Soar Y/Y on Strong MENA Demand
by Zacks Equity Research
PPIH reports a robust Q2 with earnings per share jumping to 40 cents, and a 7% rise in sales driven by a growing backlog.
PPIHPositive Net Change
earnings industrial-products
MIND Technology Q2 Loss Narrows Y/Y, Seamap Demand Drives Growth
by Zacks Equity Research
MIND incurred a net loss per share of 11 cents in the second quarter of fiscal 2025, narrowed from the prior-year quarter, with revenues rising to $10 million, reflecting operational improvements and strong Seamap demand.
MINDPositive Net Change
business-services earnings
Kewaunee Scientific's Earnings and Sales Decline Y/Y in Q1
by Zacks Equity Research
Delays in international shipments, especially in India due to customer construction site issues, impact KEQU's Q1 earnings.
KEQUNegative Net Change
earnings tech-stocks